Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
This study is ongoing, but not recruiting participants.
Study NCT00074035. Last updated on July 23, 2008.
Information provided by National Cancer Institute (NCI)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Gestational Trophoblastic Tumor
Graft Versus Host Disease
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Breast Neoplasms
Gestational Trophoblastic Neoplasms
Graft vs Host Disease
Lymphoma, Large-Cell, Immunoblastic
Multiple Myeloma
Myeloproliferative Disorders
Neoplasms, Germ Cell and Embryonal
Neoplasms, Plasma Cell
Ovarian Neoplasms
Preleukemia
Syndrome
Trophoblastic Neoplasms
More general conditions related to this trial
Adnexal Diseases
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Cardiovascular Diseases
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Diseases
Paraproteinemias
Pathologic Processes
Precancerous Conditions
Pregnancy Complications
Pregnancy Complications, Neoplastic
Skin Diseases
Urogenital Neoplasms
Vascular Diseases
Interventions listed in this trial
pentostatin
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Back to top of Main Content